AOD-9604 for Cartilage Repair
Research, mechanism, dosing, and effectiveness of AOD-9604 for cartilage repair.
Quick Answer
Recent research shows AOD-9604 promotes cartilage regeneration. Being studied for osteoarthritis.
Evidence Level
Human Trials
Typical Dose
Oral or injectable forms under study
Results Timeline
Cartilage benefits over 3-6 months
FDA Status
Research Only
How AOD-9604 Works for Cartilage Repair
Stimulates chondrocyte proliferation and proteoglycan synthesis in cartilage.
About Cartilage Repair
Regeneration of cartilage tissue for joint health and arthritis.
Research Evidence
Clinical trials showed modest weight loss effects but failed to meet primary endpoints for FDA approval. Some studies show cartilage regeneration potential. Research demonstrates safety profile similar to placebo with no significant GH-like side effects.
Dosing for Cartilage Repair
Recommended Dose
Oral or injectable forms under study
Frequency
Once daily, usually morning fasted
Administration
Subcutaneous injection or oral (studied both)
Duration
12-24 weeks in studies
Note: HGH fragment for fat loss. Take on empty stomach. Often combined with fasted cardio for enhanced fat burning.
What to Expect
Initial adjustment period. Some users may notice subtle changes.
Early benefits often become noticeable. Continue consistent use.
Most users report meaningful improvements by this point.
Full effects typically realized. Reassess and adjust as needed.
Possible Side Effects
Not everyone experiences these. Individual responses vary.
- •Generally very well-tolerated
- •Injection site reactions
- •Mild headache
- •Dizziness
- •Does NOT produce typical HGH side effects
- •No effect on IGF-1 levels
Frequently Asked Questions
Does AOD-9604 help with cartilage repair?
Recent research shows AOD-9604 promotes cartilage regeneration. Being studied for osteoarthritis.
How does AOD-9604 work for cartilage repair?
Stimulates chondrocyte proliferation and proteoglycan synthesis in cartilage....
What dose of AOD-9604 should I use for cartilage repair?
Oral or injectable forms under study
How long until I see results?
Cartilage benefits over 3-6 months
Other Peptides for Cartilage Repair
These peptides are also researched for cartilage repair.
Semaglutide
FDAA GLP-1 receptor agonist with multiple FDA approvals including weight loss, T2D, CV risk reduction, and kidney protection. Wegovy pill approved Dec 2025 as first oral GLP-1 for weight loss.
Tirzepatide
FDAA dual GIP/GLP-1 receptor agonist representing the next generation of incretin-based therapies. Shows superior weight loss compared to semaglutide in head-to-head trials. First medication approved for obstructive sleep apnea.
Retatrutide
Clinical TrialsA triple agonist targeting GLP-1, GIP, and glucagon receptors. Phase 3 trials show up to 28.7% weight loss (71 lbs average), the highest of any obesity drug. Expected FDA approval late 2026 to early 2027.
Orforglipron
Clinical TrialsAn oral non-peptide GLP-1 receptor agonist. NDA submitted to FDA with Priority Review. Expected approval by mid-2026.
Educational Information Only
This information about AOD-9604 for cartilage repair is for educational purposes only. Always consult with qualified healthcare providers before using any peptide. Individual results may vary.